At Midi, we strongly believe women should have access to treatments that can help address midlife symptoms, including weight gain
RhIGF-1 is a synthetic form of IGF-1
16.9-47% of patients met the NICE composite endpoint (weight reduction of 3% or greater and HbA1c reduction of 1% or greater)
Reduces Appetite : By acting on parts of the brain that control hunger, semaglutide decreases appetite and food intake
It also serves to regulate activities of vital organs and blood vessels and communication between nerves and muscles
As for people who should not use epitalon, we know that this group includes women who are pregnant or breastfeeding , as there isnt enough research to confirm the safety of the mother, their fetus, or their developing child